Home / Uncategorized / FDA okays Jakafi, first drug for rare marrow disease

FDA okays Jakafi, first drug for rare marrow disease

At monthly cost of $7,000, costly new medicine aimed at estimated 20,000 Americans who have myelofibrosis

Read the rest here:
FDA okays Jakafi, first drug for rare marrow disease

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top